ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

TMDX TransMedics Group Inc

146.60
3.53 (2.46%)
After Hours
Last Updated: 23:45:19
Delayed by 15 minutes
Share Name Share Symbol Market Type
TransMedics Group Inc NASDAQ:TMDX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.53 2.46% 146.60 146.01 147.00 148.4422 141.00 141.24 724,111 23:45:19

TransMedics to Present at the Piper Sandler 35th Annual Healthcare Conference

14/11/2023 9:05pm

PR Newswire (US)


TransMedics (NASDAQ:TMDX)
Historical Stock Chart


From Jun 2023 to Jun 2024

Click Here for more TransMedics Charts.

ANDOVER, Mass., Nov. 14, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will participate in a fireside chat at the upcoming Piper Sandler 35th Annual Healthcare Conference in New York. The fireside chat will take place on Tuesday, November 28, 2023, at 2:30 p.m. Eastern Time.

(PRNewsfoto/TransMedics, Inc.)

Event: Piper Sandler 35th Annual Healthcare Conference
Date: Tuesday, November 28, 2023
Time: 2:30 p.m. ET

A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. 

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
332-895-3222
Investors@transmedics.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-the-piper-sandler-35th-annual-healthcare-conference-301988157.html

SOURCE TransMedics Group, Inc.

Copyright 2023 PR Newswire

1 Year TransMedics Chart

1 Year TransMedics Chart

1 Month TransMedics Chart

1 Month TransMedics Chart

Your Recent History

Delayed Upgrade Clock